Domestic pharmaceutical innovation is active Experts: Accelerate the speed of domestic innovative drugs to go to sea

Professor Jiang Jie, dean of the Guangdong-Hong Kong-Macao Greater Bay Area Pharmaceutical and Medical Device Real-World Research Institute of Jinan University, recently said through video at the 2021 China Biomedical Enterprises Top 100 Innovative Strength Series List Conference that domestic pharmaceutical innovation is active, and favorable and negative policies guide and force enterprises to innovate
.
"Domestic enterprises should have the courage to face international competition, unswervingly carry out pharmaceutical innovation, and accelerate the speed of domestic innovative drugs to go global, only core competitiveness products are valuable
.
" He said
.
Jiang Jie introduced that China has invested a lot of research and development funds to support new drug innovation, and innovative drugs have developed rapidly from the "barbaric" era to the current first-in-class stage, from "fake innovation" to the real innovation period, and the domestic research and development capabilities of new drugs in major diseases, such as tumors
.
Zhang Buyong, chief researcher of the data information service platform in the field of medicine and health, said at the meeting that according to the data statistics of the drug clinical trial registration platform of the National Drug Review Center in recent years, the number of clinical declarations of Class 1 new drugs in China has doubled
every two years.
"R & D has become a mandatory option for pharmaceutical companies to seek development, and the R&D investment intensity of the entire industry is increasing, and the head effect of innovative pharmaceutical companies is getting stronger and stronger
.
" In 2021, 47 innovative drugs in China passed the review, hitting a record high
.
He said
.
Su Weiguo, CEO and Chief Scientific Officer of Hehuang Pharmaceutical, said, "As China's new drug research and development enters the 2.
0 era, in the next decade, I believe that China's new drug research and development will have a qualitative improvement
.
Su Weiguo said that at present, the system of new drug research and development in China has basically taken shape, and China's original innovative drugs are expected to go to the world and benefit patients around the
world.
(End) Disease tumor medicine and health enterprises